Increased fat mass, decreased lean mass, muscular mass and bone mineral density are characteristic of the body composition in GH deficiency, GH treatment reverses these abnormalities. Body composition was determined in 20 young adults with GHD diagnosed in childhood, whose GH treatment was stopped 1 year earlier. Reevaluation of GH secretion in these patients showed that 12 remained GH deficient (confirmed GHD) while eight recovered normal GH secretion (transient GHD). One year after stopping the GH treatment, patients with confirmed GHD showed an increased fat mass as compared with value at the end of the treatment; in addition a decreased bone mineral content was observed in the patients with low physical activity. There was no increased ...
Background: Patients with adult-onset growth hormone deficiency have reduced bone density and increa...
Adults with either GH deficiency (GHD) or GH excess have bone, metabolic, and somatic impairments. T...
Discontinuation of growth hormone (GH) treatment at the end of childhood growth in individuals with ...
Children and adolescents with growth hormone (GH) deficiency (GHD) have reduced bone turnover and bo...
Growth hormone (GH) is essential not only for normal growth during childhood, but also for the acqui...
Children with GH deficiency have reduced bone mass and mineral density in comparison with normal ind...
Adults with acquired GH deficiency (GHD) have been shown to have osteopenia associated with a 3-fold...
PurposeGrowth hormone (GH) plays a key role in the regulation of body composition, lipid metabolism,...
Recombinant GH therapy is normally administered to GH-deficient children in order to achieve a satis...
The current biochemical definition of severe GH deficiency (stimulated peak GH <3 μg/liter) provi...
The availability of recombinant human growth hormone (GH) has resulted in investigation of the role ...
Growth hormone deficiency (GHD) is a complex endocrine syndrome, which is most commonly known to aff...
Background/Aims: The aim of the present study was to evaluate bone mineral density (BMD) and body co...
The most common practice in children with growth hormone (GH) deficiency is to discontinue GH treatm...
textabstractAdults with childhood onset GH deficiency (GHD) have reduced bone mass, increa...
Background: Patients with adult-onset growth hormone deficiency have reduced bone density and increa...
Adults with either GH deficiency (GHD) or GH excess have bone, metabolic, and somatic impairments. T...
Discontinuation of growth hormone (GH) treatment at the end of childhood growth in individuals with ...
Children and adolescents with growth hormone (GH) deficiency (GHD) have reduced bone turnover and bo...
Growth hormone (GH) is essential not only for normal growth during childhood, but also for the acqui...
Children with GH deficiency have reduced bone mass and mineral density in comparison with normal ind...
Adults with acquired GH deficiency (GHD) have been shown to have osteopenia associated with a 3-fold...
PurposeGrowth hormone (GH) plays a key role in the regulation of body composition, lipid metabolism,...
Recombinant GH therapy is normally administered to GH-deficient children in order to achieve a satis...
The current biochemical definition of severe GH deficiency (stimulated peak GH <3 μg/liter) provi...
The availability of recombinant human growth hormone (GH) has resulted in investigation of the role ...
Growth hormone deficiency (GHD) is a complex endocrine syndrome, which is most commonly known to aff...
Background/Aims: The aim of the present study was to evaluate bone mineral density (BMD) and body co...
The most common practice in children with growth hormone (GH) deficiency is to discontinue GH treatm...
textabstractAdults with childhood onset GH deficiency (GHD) have reduced bone mass, increa...
Background: Patients with adult-onset growth hormone deficiency have reduced bone density and increa...
Adults with either GH deficiency (GHD) or GH excess have bone, metabolic, and somatic impairments. T...
Discontinuation of growth hormone (GH) treatment at the end of childhood growth in individuals with ...